Drupal.behaviors.print = function(context) {window.print();window.close();}>
HealthLinx Announces Data Demonstrating Potential of Protein Marker as Ovarian Cancer Prognostic
February 17, 2012
HealthLinx Announces Data Demonstrating Potential of Protein Marker as Ovarian Cancer Prognostic
Full-text access for premium subscribers only.
Existing premium subscribers
login here
.
New to GenomeWeb?
Register here
quickly.
Related Stories
Healthlinx Signs $9M Financing Deal to Drive Expansion of OvPlex into US
December 16, 2011 / ProteoMonitor
Court Approves Sale of Correlogic’s Assets to Vermillion after Second Bidder Drops Out
December 2, 2011 / ProteoMonitor
Vermillion Buys Correlogic's Assets for $435K; Correlogic Settles with LabCorp, Quest
November 11, 2011 / ProteoMonitor
Is Healthlinx Eyeing Purchase of Correlogic's Assets as Part of Move into US Cancer Dx Market?
October 14, 2011 / ProteoMonitor
HealthLinx Releases Initial Results from First Stage of 1,150-Subject OvPlex Study
December 17, 2010 / ProteoMonitor